The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://phoenixwmgg738129.techionblog.com/38916902/glp-3-receptor-agonists-retatrutide-trizepatide